Skip to main content
HCPCS J0282 · Level II · Part B drug

HCPCS J0282: Injection, amiodarone hydrochloride, 30 mg

Reviewed by QuickIntell RCM Editorial Team · Last reviewed

Data effective
Data currency: ASP payment limits October 2026 (effective October 1, 2026); MUE and NCCI edits 2026 Q4 (effective October 1, 2026); OPPS Addendum B July 2026 (effective July 1, 2026). Next CMS release: January 1, 2027 (ASP, MUE, NCCI and OPPS quarterly updates).

Key facts for J0282

Billing unit
30 MG
Amiodarone hcl
ASP payment limit
$0.384
October 2026; -4.0% vs July 2026
Practitioner MUE
35
MAI 3
OPPS status
SI N
NCCI exposure
no PTP pairs
Coverage articles
0
none list this code

TL;DR

HCPCS J0282 is the Level II code for Injection, amiodarone hydrochloride, 30 mg, billed per 30 MG. The Medicare Part B ASP payment limit for October 2026 is $0.384 per billing unit, down 4.0% from July 2026. The practitioner MUE allows up to 35 units per date of service (MAI 3). Under OPPS it carries status indicator N. J0282 is billed in units of 30 MG; the quantity administered, the NDC package and the units on the claim must reconcile, which is the check that prevents CARC 16 and 151 returns on this line. The ASP crosswalk maps 18 NDCs to it, sold as Amiodarone HCl by Hikma Pharmaceuticals USA Inc., Henry Schein Inc., Sagent Pharmaceuticals. No current Billing and Coding Article lists J0282, so coverage follows the FDA label, compendia and any applicable NCD.

Medicare Part B payment limit (ASP)

CMS sets the Part B payment limit for J0282 at $0.384 per 30 MG for October 2026, derived from manufacturer average sales price plus 6%, compared with $0.40 in July 2026. Beneficiary coinsurance is 20%.

ASP payment limits for J0282
QuarterPayment limitPerCoinsurance
October 2026$0.38430 MG20%
July 2026$0.4030 MG—
Source: CMS Medicare Part B Drug Payment Limit File. Commercial and Medicaid payers set their own rates.

NDC to HCPCS billing-unit conversion

The October 2026 ASP crosswalk maps 18 NDCs from 7 labelers to J0282. Report the NDC in the claim's drug segment and bill the number of J0282 units that equals the quantity administered divided by 30 MG; the last column gives units per full package.

NDCs that crosswalk to J0282
NDCDrug nameLabelerPackage sizeBilling units / package
00143-9875-25Amiodarone HClHikma Pharmaceuticals USA Inc.3 × 25125
00404-9772-03Amiodarone HClHenry Schein Inc.3 × 15
00404-9815-03Amiodarone HClHenry Schein Inc.3 × 15
25021-0302-66Amiodarone HClSagent Pharmaceuticals3 × 1050
51662-1205-01Amiodarone HClHF Acquisition Co. LLC, DBA HealthFirst3 × 15
51662-1205-03Amiodarone HClHF Acquisition Co. LLC, DBA HealthFirst3 × 25125
51662-1358-01Amiodarone HClHF Acquisition Co. LLC, DBA HealthFirst18 × 130
51662-1363-01Amiodarone HClHF Acquisition Co. LLC, DBA HealthFirst3 × 15
63323-0616-03Amiodarone HClFreseniUS Kabi USA, LLC3 × 25125
63323-0616-09Amiodarone HClFreseniUS Kabi USA, LLC9 × 10150
67457-0153-03Amiodarone HClMylan Institutional LLC3 × 1050
67457-0153-09Amiodarone HClMylan Institutional LLC9 × 10150
67457-0153-18Amiodarone HClMylan Institutional LLC18 × 130
70436-0232-50Amiodarone HClSlate Run Pharmaceuticals18 × 130
70436-0232-52Amiodarone HClSlate Run Pharmaceuticals3 × 1050
70436-0232-62Amiodarone HClSlate Run Pharmaceuticals9 × 10150
72078-0046-09Amiodarone HClMylan Institutional LLC9 × 10150
72078-0046-18Amiodarone HClMylan Institutional LLC18 × 130

Medically Unlikely Edits (MUE)

CMS publishes 3 MUE values for J0282. For practitioners the limit is 35 units per date of service with adjudication indicator 3, a date-of-service clinical edit: units above the limit deny but can be paid on appeal with documentation that the quantity was medically reasonable.

MUE values for J0282 by setting
SettingMUE (units/DOS)MAICMS rationale
Practitioner services353 Date of Service Edit: ClinicalPrescribing Information
Facility outpatient hospital703 Date of Service Edit: ClinicalClinical: Data
DME supplier353 Date of Service Edit: ClinicalPrescribing Information

NCCI edits and add-on relationships

No active practitioner PTP pair lists J0282 as a column-1 or column-2 code in v323r0. Drug supply codes are rarely bundled; the administration codes billed with them are where PTP edits usually apply.

J0282 is neither an add-on code nor a designated primary code in the 2026 Q4 NCCI add-on edit file.

Medicare coverage articles

No current Billing and Coding Article lists J0282 in its HCPCS table. Coverage then follows the drug's FDA label, compendia and any National Coverage Determination; check the Medicare Coverage Database before administering off-label.

Hospital outpatient (OPPS) status

In the July 2026 OPPS Addendum B, J0282 carries status indicator N. Status N means payment is packaged into the associated procedure and no separate OPPS payment is made.

Common denials for J0282 and how to prevent them

CARC 16 · M119

NDC missing, invalid or not matched to the HCPCS code

CARC 151 · N362

units billed exceed the MUE for the date of service

CARC 50 · N115

diagnosis not covered by the applicable coverage article or LCD

How QuickIntell checks J0282 before the claim leaves

QuickCode validates the NDC-to-unit conversion against the current ASP crosswalk, checks units against every published MUE setting and flags PTP and add-on conflicts on the same claim. QuickRCM routes CARC 16, 151 and 50 denials on drug lines with the matching coverage article attached so the appeal starts with evidence.

Explore QuickCodeExplore QuickRCMBook a demo

Frequently asked questions — HCPCS J0282

What does HCPCS code J0282 describe?

J0282 is defined by CMS as "Injection, amiodarone hydrochloride, 30 mg". Each billing unit represents 30 MG, so the units reported on the claim must equal the dose administered divided by that unit.

What is the Medicare reimbursement for J0282 in October 2026?

The ASP-based payment limit is $0.384 per 30 MG, with 20% beneficiary coinsurance. Medicare Administrative Contractors apply this limit; commercial payers use their own fee schedules. The July 2026 limit was $0.40.

How many units of J0282 can be billed per day?

The practitioner Medically Unlikely Edit is 35 units per date of service with adjudication indicator 3 (3 Date of Service Edit: Clinical). MAI 3 edits can be appealed with documentation that the units were medically reasonable. CMS cites "Prescribing Information" as the rationale.

Which NDCs map to J0282?

The October 2026 ASP crosswalk lists 18 NDCs from 7 labelers: Amiodarone HCl (Hikma Pharmaceuticals USA Inc.); Amiodarone HCl (Henry Schein Inc.); Amiodarone HCl (Sagent Pharmaceuticals); Amiodarone HCl (HF Acquisition Co. LLC, DBA HealthFirst). For example NDC 00143-9875-25 is a 3 package equal to 125 billing units. The crosswalk's billing-units-per-package figure converts each package into J0282 units.

Does J0282 have NCCI bundling edits?

No active practitioner PTP pairs list J0282 as a column-1 or column-2 code in the v323r0 release. Unit limits (MUE) and medical-necessity coverage rules still apply.

Sources

Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-10-01. Verify against the primary file before billing or contracting decisions.

Disclaimer

This page is an operational reference compiled from CMS publications: the Medicare Part B drug payment limit and NDC crosswalk files, NCCI MUE and add-on edit tables, aggregate PTP statistics, OPPS Addendum B and the Medicare Coverage Database. Payment limits are Medicare national amounts; commercial and Medicaid payers differ. CPT codes are shown as numbers only; CPT descriptors are copyright AMA. Nothing here is legal, clinical or billing advice.